Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Receipt of Letter From NASDAQ Confirming Compliance With Minimum Bid Price Requirement

BUFFALO, NY--(Marketwired - Feb 18, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on February 12, 2015, the Company received a letter from The NASDAQ Stock Market stating that...
February 17, 2015 10:34 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Report Fourth Quarter and Fiscal Year 2014 Financial Results on February 24

BUFFALO, NY--(Marketwired - Feb 17, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on February 24, 2015, it will report its financial results for the fourth quarter and fiscal...
February 11, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents

BUFFALO, NY--(Marketwired - Feb 11, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the issuance of several new patents for entolimod in the U.S. and other countries, further...
February 10, 2015 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Annual Meeting

BUFFALO, NY--(Marketwired - Feb 10, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will hold its 2015 Annual Meeting of Stockholders on April 14, 2015 in Buffalo, NY...
February 05, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at 2015 BIO CEO & Investor Conference

BUFFALO, NY--(Marketwired - Feb 5, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 2015 BIO CEO & Investor Conference, February...
February 04, 2015 09:05 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces $4.2 Million Financing

BUFFALO, NY--(Marketwired - Feb 4, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into definitive agreements with two institutional investors to purchase a...
January 29, 2015 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Oncology Clinical Development Update for Entolimod

BUFFALO, NY--(Marketwired - Jan 29, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced updates on oncology clinical development of entolimod (previously known as CBLB502). ...
January 28, 2015 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Board Appointment

BUFFALO, NY--(Marketwired - Jan 28, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Elena Kasimova of BioProcess Capital Partners to the Company's Board of...
January 27, 2015 16:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Results of Special Meeting of Stockholders and Reverse Stock Split

BUFFALO, NY--(Marketwired - Jan 27, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that at a special meeting of stockholders held on January 27, 2015, stockholders authorized the...
January 12, 2015 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Receives Department of Defense Support to Further Development of Entolimod (CBLB502) as a Medical Radiation Countermeasure

BUFFALO, NY--(Marketwired - Jan 12, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company received notice that the proposal application to support further development of...